Abstract
Objective Given possible airborne transmission of SARS-CoV-2, an overview of reviews was conducted to understand what is already known from the scientific literature about how virus transmission may be affected by heating, ventilation, and air-conditioning (HVAC) design features in the built environment.
Methods Ovid MEDLINE and Compendex were searched from inception to January 2021. Two reviewers independently screened titles and abstracts and full text of potentially relevant reviews, using a priori inclusion criteria. Inclusion criteria were systematic reviews examining effects of HVAC design features on virus transmission. Two reviewers independently assessed methodological quality using AMSTAR2.
Results Searching identified 361 citations, 45 were potentially relevant, and 7 were included. Reviews were published between 2007 and 2021, and included 47 virus studies. Two earlier reviews (2007, 2016) of 21 studies found sufficient evidence that mechanical ventilation (airflow patterns, ventilation rates) plays a role in airborne transmission; however, both found insufficient evidence to quantify minimum mechanical ventilation requirements. One review (2017) of 9 studies examining humidity and indoor air quality found that influenza virus survival was lowest between 40% and 80% relative humidity; authors noted that ventilation rates were a confounding variable. Two reviews (2021) examined mitigation strategies for coronavirus transmission, finding droplet transmission decreased with increasing temperature and relative humidity. One review (2020) identified 14 studies examining coronavirus transmission in air-conditioning systems, finding HVAC systems played a role in virus spread during previous coronavirus outbreaks. One review (2020) examined virus transmission interventions on public ground transportation, finding ventilation and filtration to be effective.
Discussion Seven reviews synthesizing 47 studies demonstrate a role of HVAC in mitigating airborne virus transmission. Ventilation, humidity, temperature, and filtration can play a role in viability and transmission of viruses, including coronaviruses. Recommendations for minimum standards were not possible due to few studies investigating a given HVAC parameter.
This overview synthesized seven previous reviews that included 47 studies examining HVAC design features and their effects on airborne transmission of viruses, serving as a starting point for future systematic reviews and identifying priorities for primary research.
The strengths of this study include its comprehensiveness and use of methods to avoid bias, such as pre-specification of inclusion/exclusion criteria and involvement of at least two reviewers at all stages.
The main limitation stems from the limits of the included reviews because many reviews did not meet the internationally recognized definitions and methodological expectations of systematic reviews.
Competing Interest Statement
Dr. Fleck is an unpaid advisor for Pura Air Inc. in Vancouver. None of the other authors has competing interests.
Funding Statement
This work is funded by a Canadian Institutes of Health Research (CIHR) Operating Grant: Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity [https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=422567; grant number: not applicable]. Dr. Hartling is supported by a Canada Research Chair (Tier 1) in Knowledge Synthesis and Translation. The funders had no role in the project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable because this is an overview of reviews.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
No additional data available. All data are available in the manuscript and the supplemental material.
